Moderate to Severe Chronic Plaque Psoriasis

DrugDrug NameDrug Description
DB00051AdalimumabA monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DB00095EfalizumabA monoclonal anti-CD11a antibody used to treat moderate to severe plaque psoriasis.
DrugDrug NamePhaseStatusCount
DB06410Doxercalciferol2Completed1
DB12917Bimekizumab3Active Not Recruiting3
DB12917Bimekizumab3Completed2
DB09029Secukinumab3Active Not Recruiting1
DB05679Ustekinumab3Completed1
DB05679Ustekinumab3Recruiting1
DB00092Alefacept4Completed1